William D. Humphries's Net Worth
$6.05 Million
Who is William D. Humphries?
William D. Humphries has an estimated net worth of $6.05 Million. This is based on reported shares across multiple companies, which include Valeant Pharmaceuticals International, Inc., Aclaris Therapeutics, Inc., PhaseBio Pharmaceuticals Inc, STRATA Skin Sciences, Inc., and Clearside Biomedical, Inc..
SEC CIK
William D. Humphries's CIK is 0001674278
Past Insider Trading and Trends
2020 was William D. Humphries's most active year for acquiring shares with 14 total transactions. William D. Humphries's most active month to acquire stocks was the month of May. 2020 was William D. Humphries's most active year for disposing of shares, totalling 16 transactions. William D. Humphries's most active month to dispose stocks was the month of October. 2020 saw William D. Humphries paying a total of $2,179,295.50 for 420,088 shares, this is the most they've acquired in one year. In 2020 William D. Humphries cashed out on 422,427 shares for a total of $5,147,158.23, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Valeant Pharmaceuticals International, Inc. (BHC) Snapshot price: $6.1229
President, Ortho-Dermatologics
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$17.13 | -$626,287.41 | 235.03K |
Dec 4
| |||
Form 4
|
—
|
0
|
$17.01 | -$193,277.70 | 728.25K |
Nov 23 - Nov 27
| |||
Form 4
| -2.35% | -5.67K |
$16.17 | -$91,635.39 | 235.03K |
Scheduled
|
Sep 8
| ||
Form 4
| -1.86% | -4.57K |
$17.48 | -$79,831.16 | 240.7K |
Aug 17
| |||
Form 4
| -0.91% | -2.26K |
$24.44 | -$55,332.16 | 245.27K |
Feb 28
| |||
Form 4
| +5.77% | 13.51K |
—
|
—
| 247.53K |
Feb 26
| |||
Form 4
| +42.82% | 70.16K |
$26.46 | -$1,495,836.72 | 234.03K |
Feb 19 - Feb 20
| |||
Form 4
| -8.16% | -14.56K |
$29.92 | -$435,605.28 | 163.87K |
Jan 3
| |||
Form 4
| +52.48% | 61.41K |
$21.18 | $650,142.17 | 178.42K |
Aug 16
| |||
Form 4
| +14.95% | 15.22K |
—
|
—
| 117.02K |
Feb 27
| |||
Form 4
| -11.56% | -13.31K |
$18.47 | -$245,854.17 | 101.8K |
Jan 3
| |||
Form 4
| -11.34% | -14.73K |
$20.78 | -$306,089.40 | 115.11K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 129.84K |
—
|
—
| 129.84K |
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +19.36% | 4.66K |
—
|
—
| 28.73K |
Jun 1
| |||
Form 4
| +23.04% | 4.51K |
—
|
—
| 24.07K |
Jun 1 - Jun 2
| |||
Form 4
| +20.70% | 3.36K |
—
|
—
| 19.57K |
Jun 2 - Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +82.62% | 7.33K |
—
|
—
| 16.21K |
Jun 4 - Jun 6
| |||
Form 4
|
∞
| 8.88K |
—
|
—
| 8.88K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.54K |
—
|
—
| 2.54K |
May 19
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
STRATA Skin Sciences, Inc. (SSKN) Snapshot price: $3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +49.66% | 36.41K |
$1.03 | $37,500.24 | 109.72K |
Jul 5
| |||
Form 4
| +3.63% | 16.95K |
$1.73 | $29,384.52 | 484.44K |
Mar 25
| |||
Form 4
| +3.27% | 14.78K |
$1.58 | $23,386.71 | 467.49K |
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 4
|
∞
| 41.58K |
—
|
—
| 41.58K |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Clearside Biomedical, Inc. (CLSD) Snapshot price: $0.9799
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +80.27% | 22.73K |
$0.40 | $9,090.80 | 51.04K |
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +406.86% | 22.73K |
$0.15 | $3,409.05 | 28.31K |
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
∞
| 5.59K |
$1.78 | $9,943.08 | 5.59K |
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||